Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Operations: 2020-2024

Historic Cash from Operations for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to -$57.7 million.

  • Pyxis Oncology's Cash from Operations rose 9.46% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.4 million, marking a year-over-year change of. This contributed to the annual value of -$57.7 million for FY2024, which is 18.44% up from last year.
  • As of FY2024, Pyxis Oncology's Cash from Operations stood at -$57.7 million, which was up 18.44% from -$70.7 million recorded in FY2023.
  • Pyxis Oncology's 5-year Cash from Operations high stood at -$10.1 million for FY2020, and its period low was -$89.3 million during FY2022.
  • Over the past 3 years, Pyxis Oncology's median Cash from Operations value was -$70.7 million (recorded in 2023), while the average stood at -$72.6 million.
  • Per our database at Business Quant, Pyxis Oncology's Cash from Operations tumbled by 250.32% in 2021 and then climbed by 20.85% in 2023.
  • Pyxis Oncology's Cash from Operations (Yearly) stood at -$10.1 million in 2020, then tumbled by 250.32% to -$35.3 million in 2021, then slumped by 152.89% to -$89.3 million in 2022, then grew by 20.85% to -$70.7 million in 2023, then rose by 18.44% to -$57.7 million in 2024.